Arch Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2011 to Q4 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Arch Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2011 to Q4 2023.
- Arch Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending December 31, 2023 was -$863K, a 32.7% decline year-over-year.
- Arch Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$3.37M, a 24.3% increase from 2022.
- Arch Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$4.46M, a 25.2% increase from 2021.
- Arch Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$5.96M, a 18.1% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)